Evaluating the effective use of RapidPro (Real-time SMS Reporting and Feedback Platform) for the measles and rubella campaign in Indonesia

Not Applicable

Completed

• Conditions: Measles Rubella; Infections and Infestations

• Registration Number: ISRCTN10850448
• Lead Sponsor: Gavi, The Vaccine Alliance

Brief Summary

2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33303436/ results (added 11/01/2021)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-09-17
• Study Completion: 2018-12-31
• Last Update Posted: 29 August 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 81

Inclusion Criteria

Participants should be any of the following:
1. Central level: Immunisation program managers at MoH, UNICEF, and WHO
2. Province level: Immunisation program managers at Province Health Offices
3. District level: Immunisation program managers at District Health Offices
4. Sub-district level: Immunisation coordinators at community health center (Pusat Kesehatan Masyarakat)

Exclusion Criteria

1. Stakeholders who are not entering and/or receiving RapidPro data
2. Stakeholders who are not stationed at selected study sites
3. Stakeholders who decline to participate on study.

Study & Design

• Study Type: Observational
• Study Design: Not specified